Focus Your Search
Focus Your Search
(all filters optional)
| Study Title | NCT Number | Status | Conditions | Interventions | Sponsor | Study Type |
|---|---|---|---|---|---|---|
| An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer | NCT02632409 | ACTIVE_NOT_RECRUITING | Various Advanced Cancer |
| Bristol-Myers Squibb | INTERVENTIONAL |
| Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | NCT05691244 | RECRUITING | Acute Ischemic Stroke Cerebral Stroke |
| Pharmazz, Inc. | INTERVENTIONAL |
| Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib | NCT04486833 | RECRUITING | Carcinoma, Non-Small Cell Lung |
| Genprex, Inc. | INTERVENTIONAL |
| N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer | NCT07217496 | NOT_YET_RECRUITING | Metastatic Urothelial Carcinoma Urothelial Carcinoma Locally Advanced Urothelial Carcinoma Urothelial Cancer |
| Vadim S Koshkin | INTERVENTIONAL |
| A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) | NCT05254743 | RECRUITING | Chronic Lymphocytic Leukemia Leukemia, Lymphocytic Leukemia, B-cell Small Lymphocytic Lymphoma |
| Loxo Oncology, Inc. | INTERVENTIONAL |
| Study of AZD2811 + Durvalumab in ES-SCLC | NCT04745689 | ACTIVE_NOT_RECRUITING | Small-Cell Lung Cancer |
| AstraZeneca | INTERVENTIONAL |
| A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis | NCT06311682 | RECRUITING | Atopic Dermatitis |
| LEO Pharma | INTERVENTIONAL |
| Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer | NCT03520686 | ACTIVE_NOT_RECRUITING | Non Small Cell Lung Cancer |
| ImmunityBio, Inc. | INTERVENTIONAL |
| PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation | NCT05639751 | COMPLETED | Advanced Solid Tumor Metastatic Solid Tumor Non-small Cell Lung Cancers SMARCA4 Gene Mutation |
| Prelude Therapeutics | INTERVENTIONAL |
| A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2 | NCT06952530 | RECRUITING | Hypertension |
| Eli Lilly and Company | INTERVENTIONAL |
| RAD 1501: A Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery | NCT02708810 | ACTIVE_NOT_RECRUITING | Trigeminal Neuralgia |
| University of Alabama at Birmingham | INTERVENTIONAL |
| A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) | NCT06653153 | ACTIVE_NOT_RECRUITING | Alzheimer's Disease |
| Eli Lilly and Company | INTERVENTIONAL |
| Is Our Microbiome a Predictor of Cardiac Risk | NCT02013284 | ENROLLING_BY_INVITATION | Coronary Artery Disease | N/A | Mayo Clinic | OBSERVATIONAL |
| A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors | NCT06804824 | RECRUITING | Advanced Solid Tumors |
| Vividion Therapeutics, Inc. | INTERVENTIONAL |
| A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart | NCT06935370 | RECRUITING | Heart Failure |
| Boehringer Ingelheim | INTERVENTIONAL |
| Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma | NCT05484622 | RECRUITING | Astrocytoma Oligodendroglioma |
| Institut de Recherches Internationales Servier | INTERVENTIONAL |
| Elbow Artery Embolization for Tennis Elbow | NCT05325242 | RECRUITING | Lateral Epicondylitis, Unspecified Elbow |
| Siddharth Padia, MD | INTERVENTIONAL |
| Investigating the Impact of Obesity on Pubertal Development in Girls | NCT02583646 | RECRUITING | Obesity Puberty Normal Physiology | N/A | National Institute of Environmental Health Sciences (NIEHS) | OBSERVATIONAL |
| Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis | NCT04480853 | RECRUITING | Multiple Sclerosis |
| Novartis Pharmaceuticals | INTERVENTIONAL |
| A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) | NCT05296798 | RECRUITING | Locally Advanced or Metastatic Breast Cancer |
| Hoffmann-La Roche | INTERVENTIONAL |
| An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial | NCT06999798 | RECRUITING | Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Locally Advanced Breast Carcinoma |
| Mayo Clinic | INTERVENTIONAL |
| Cancer Within a Pandemic: A Telemental Health Intervention | NCT04659993 | TERMINATED | Cancer Survivorship Depression, Anxiety |
| Wake Forest University Health Sciences | INTERVENTIONAL |
| Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma | NCT06563102 | RECRUITING | Mild Asthma |
| AstraZeneca | INTERVENTIONAL |
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide | NCT06897475 | RECRUITING | Type 2 Diabetes |
| Eli Lilly and Company | INTERVENTIONAL |
| QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer | NCT03022825 | ACTIVE_NOT_RECRUITING | Bladder Cancer |
| ImmunityBio, Inc. | INTERVENTIONAL |
| Integrative Medicine in Pain Management in Sickle Cell Disease | NCT05045820 | ACTIVE_NOT_RECRUITING | Sickle Cell Disease Pain Acupuncture Quantitative Sensory Testing |
| Indiana University | INTERVENTIONAL |
| An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus | NCT05352919 | ENROLLING_BY_INVITATION | Systemic Lupus Erythematosus (SLE) |
| Biogen | INTERVENTIONAL |
| A PHASED, PROSPECTIVE, MULTI-CENTER STUDY OF THE ELITA SYSTEM | NCT05713253 | TERMINATED | Refractive Error |
| Johnson & Johnson Surgical Vision, Inc. | INTERVENTIONAL |
| Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation | NCT06427811 | ACTIVE_NOT_RECRUITING | Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase |
| Novartis Pharmaceuticals | INTERVENTIONAL |
| Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia | NCT04652726 | COMPLETED | Familial Hypercholesterolemia - Heterozygous |
| Novartis Pharmaceuticals | INTERVENTIONAL |
| Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine | NCT05738213 | ACTIVE_NOT_RECRUITING | Migraine |
| Washington University School of Medicine | INTERVENTIONAL |
| Expanded Access [11C] Methionine PET Imaging | NCT05511714 | AVAILABLE | Central Nervous System Tumor Head and Neck Neoplasms |
| St. Jude Children's Research Hospital | EXPANDED_ACCESS |
| DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers | NCT05882058 | RECRUITING | Small Cell Lung Carcinoma Neuroendocrine Neoplasms Extra-pulmonary Neuroendocrine Carcinoma |
| Boehringer Ingelheim | INTERVENTIONAL |
| A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee | NCT07153471 | RECRUITING | Osteoarthritis |
| Eli Lilly and Company | INTERVENTIONAL |
| E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs | NCT06443385 | ACTIVE_NOT_RECRUITING | Opioid Prescribing Prescription Drug Misuse |
| Columbia University | INTERVENTIONAL |
| S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP | NCT06188702 | RECRUITING | MTAP-deleted Solid Tumors |
| Servier Bio-Innovation LLC | INTERVENTIONAL |
| Left Bundle Branch Area Pacing (LBBAP) PMCF Study | NCT07217392 | RECRUITING | Bradycardia Right Ventricular Pacing Heart Failure Atrial Fibrillation (AF) |
| Abbott Medical Devices | INTERVENTIONAL |
| N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma | NCT06061809 | ACTIVE_NOT_RECRUITING | Glioblastoma |
| ImmunityBio, Inc. | INTERVENTIONAL |
| A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) | NCT05716100 | RECRUITING | Focal Onset Seizures |
| Xenon Pharmaceuticals Inc. | INTERVENTIONAL |
| Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI) | NCT07149428 | NOT_YET_RECRUITING | Respiratory Tract Infection Smell Disorder Influenza Rhinosinusitis | N/A | National Institute on Deafness and Other Communication Disorders (NIDCD) | OBSERVATIONAL |
| Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus | NCT04370795 | ENROLLING_BY_INVITATION | Severe Combined Immune Deficiency (SCID) |
| National Institute of Allergy and Infectious Diseases (NIAID) | INTERVENTIONAL |
| Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B) | NCT07027839 | RECRUITING | Alcohol Use Disorder |
| National Institute of Mental Health (NIMH) | INTERVENTIONAL |
| Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC) | NCT07217717 | NOT_YET_RECRUITING | Pancreatic Ductal Adenocarcinoma (PDAC) |
| SOFIE | INTERVENTIONAL |
| A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease | NCT07190196 | RECRUITING | Immunoglobulin G4 Related Disease |
| Sanofi | INTERVENTIONAL |
| Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation | NCT03856216 | TERMINATED | Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia Lymphocytic Neoplasm Lymphoma |
| M.D. Anderson Cancer Center | INTERVENTIONAL |
| A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation | NCT04449874 | ACTIVE_NOT_RECRUITING | Non-Small Cell Lung Cancer Colorectal Cancer Advanced Solid Tumors |
| Genentech, Inc. | INTERVENTIONAL |
| Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer | NCT06829823 | NOT_YET_RECRUITING | Non-muscle Invasive Bladder Cancer (NMIBC) |
| ImmunityBio, Inc. | INTERVENTIONAL |
| Genetic Analysis of Uncommon Disease Presentations in Non-US Populations | NCT06595940 | RECRUITING | Undiagnosed Diseases Rare Diseases | N/A | National Human Genome Research Institute (NHGRI) | OBSERVATIONAL |
| A Study of LY4175408 in Participants With Advanced Cancer | NCT07046923 | RECRUITING | Carcinoma, Non-Small-Cell Lung Small Cell Lung Carcinoma Endometrial Neoplasms Neoplasm Metastasis |
| Eli Lilly and Company | INTERVENTIONAL |
| L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML | NCT06788756 | RECRUITING | Acute Myeloid Leukaemia (AML) |
| Moleculin Biotech, Inc. | INTERVENTIONAL |
| The GRoceries Aimed at Increasing Nutrition Study | NCT07167004 | RECRUITING | Type 2 Diabetes Type II Diabetes Mellitus Type II Diabetes Pre-diabetes |
| University of Pennsylvania | INTERVENTIONAL |
| Project: Every Child for Younger Patients With Cancer | NCT02402244 | RECRUITING | Adrenal Gland Pheochromocytoma Carcinoma In Situ Central Nervous System Neoplasm Childhood Immature Teratoma |
| Children's Oncology Group | OBSERVATIONAL |
| Extension Study (Extended Access) of Syk-inhibition Using Fostamatinib to Treat Posttransplant Immune-mediated Cytopenias | NCT05509582 | ENROLLING_BY_INVITATION | Immune Mediated Anemia Immune Mediated Thrombocytopenia Chronic GVHD |
| National Heart, Lung, and Blood Institute (NHLBI) | INTERVENTIONAL |
| Phase IIIb, Open-label, Multi-center Study to Evaluate Safety, Tolerability and Efficacy of OAV101 Administered Intrathecally to Participants With SMA Who Discontinued Treatment With Nusinersen or Risdiplam | NCT05386680 | COMPLETED | Spinal Muscular Atrophy |
| Novartis Pharmaceuticals | INTERVENTIONAL |
| LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) | NCT05321420 | ACTIVE_NOT_RECRUITING | Idiopathic Pulmonary Fibrosis |
| PureTech | INTERVENTIONAL |
| A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy | NCT06769048 | RECRUITING | Geographic Atrophy |
| Boehringer Ingelheim | INTERVENTIONAL |
| Optimization of Commissural Alignment During Transcatheter Aortic Valve Implantation With Evolut FX+ | NCT07217691 | NOT_YET_RECRUITING | Aortic Stenosis Trans-catheter Aortic Valve Implantation Commissural Alignment |
| Oslo University Hospital | INTERVENTIONAL |
| Genetic Analyses of Nonsyndromic and Syndromic Deafness in Pakistan | NCT00341874 | ENROLLING_BY_INVITATION | Hearing Disorder | N/A | National Institute on Deafness and Other Communication Disorders (NIDCD) | OBSERVATIONAL |
| ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours | NCT06597721 | RECRUITING | Advanced Solid Tumor |
| Adcendo ApS | INTERVENTIONAL |
| NHLBI-Emory Advanced Cardiac CT Reconstruction | NCT05372627 | NOT_YET_RECRUITING | Structural Heart Disease | N/A | National Heart, Lung, and Blood Institute (NHLBI) | OBSERVATIONAL |
| Assessment of a Fruit and Vegetable Prescription Program for Children | NCT04767282 | COMPLETED | Exposure to Fruit and Vegetable Prescription Program |
| Michigan State University | INTERVENTIONAL |
| A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults | NCT05703607 | RECRUITING | Shingles Herpes Zoster Infection Human |
| Pfizer | INTERVENTIONAL |
| A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors | NCT05954312 | RECRUITING | Advanced Solid Tumors |
| Vividion Therapeutics, Inc. | INTERVENTIONAL |
| Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy | NCT07186192 | RECRUITING | Hematologic Malignancies |
| City of Hope Medical Center | INTERVENTIONAL |
| A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD) | NCT06450639 | RECRUITING | Duchenne Muscular Dystrophy |
| Hoffmann-La Roche | INTERVENTIONAL |
| Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE) | NCT06041503 | NOT_YET_RECRUITING | Adenocarcinoma of the Bladder Squamous Cell Carcinoma of the Bladder Testicular Germ Cell Tumors |
| National Cancer Institute (NCI) | INTERVENTIONAL |
| The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study | NCT04818034 | COMPLETED | Cystinuria |
| University of California, San Francisco | INTERVENTIONAL |
| Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis | NCT07217587 | NOT_YET_RECRUITING | Myasthenia Gravis |
| Janssen Research & Development, LLC | INTERVENTIONAL |
| 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer | NCT06991738 | NOT_YET_RECRUITING | Thyroid Cancer |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | INTERVENTIONAL |
| STEMVAC in Patients With Early Stage Triple Negative Breast Cancer | NCT05455658 | ACTIVE_NOT_RECRUITING | Anatomic Stage IB Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage IIA Breast Cancer AJCC v8 Anatomic Stage IIB Breast Cancer AJCC v8 |
| University of Washington | INTERVENTIONAL |
| Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression | NCT03507608 | COMPLETED | Prostate Cancer |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | INTERVENTIONAL |
| Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) | NCT06117774 | RECRUITING | Limited Stage Small Cell Lung Cancer Small Cell Lung Cancer |
| Amgen | INTERVENTIONAL |
| Prospective Evaluation of Silk Fibroin Incision Dressings in ACL Reconstruction | NCT07217613 | NOT_YET_RECRUITING | Anterior Cruciate Ligament Reconstruction |
| NYU Langone Health | INTERVENTIONAL |
| SMART-r: Substance Monitoring and Active Relapse Tracking Repository | NCT06676059 | RECRUITING | Alcoholism Substance-Related Disorders | N/A | National Institute on Drug Abuse (NIDA) | OBSERVATIONAL |
| An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA) | NCT03769168 | COMPLETED | Juvenile Psoriatic Arthritis Enthesitis Related Arthritis |
| Novartis Pharmaceuticals | INTERVENTIONAL |
| A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer Treatment | NCT05889091 | RECRUITING | Head and Neck Squamous Cell Carcinoma |
| Memorial Sloan Kettering Cancer Center | INTERVENTIONAL |
| A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats | NCT06049797 | ACTIVE_NOT_RECRUITING | Hot Flashes |
| Astellas Pharma Global Development, Inc. | OBSERVATIONAL |
| A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis | NCT06028438 | COMPLETED | Arthritis, Rheumatoid |
| Janssen Research & Development, LLC | INTERVENTIONAL |
| A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) | NCT06077760 | RECRUITING | Non-small Cell Lung Cancer |
| Merck Sharp & Dohme LLC | INTERVENTIONAL |
| Baricitinib in the Treatment of Kohlmeier-Degos Disease in Patients With Neurological Involvement | NCT06923072 | RECRUITING | Kohlmeier-Degos Disease Malignant Atrophic Papulosis Degos Disease Papulosis, Malignant Atrophic |
| National Heart, Lung, and Blood Institute (NHLBI) | INTERVENTIONAL |
| Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation | NCT02669251 | ACTIVE_NOT_RECRUITING | Chronic Graft vs Host Disease Chronic Graft-Versus-Host Disease Bronchiolitis Obliterans Syndrome |
| National Cancer Institute (NCI) | INTERVENTIONAL |
| PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) | NCT07169630 | RECRUITING | Alzheimer s Disease Mild Cognitive Impairment Healthy |
| National Institute of Mental Health (NIMH) | INTERVENTIONAL |
| A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine | NCT07018700 | RECRUITING | Episodic Migraine |
| Merz Therapeutics GmbH | INTERVENTIONAL |
| Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study | NCT04593277 | ACTIVE_NOT_RECRUITING | Clinical Stage I Cutaneous Melanoma AJCC v8 Clinical Stage II Cutaneous Melanoma AJCC v8 Clinical Stage III Cutaneous Melanoma AJCC v8 Hematopoietic and Lymphoid Cell Neoplasm |
| Fred Hutchinson Cancer Center | INTERVENTIONAL |
| A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma. | NCT05228470 | ACTIVE_NOT_RECRUITING | Elranatamab Myeloma Multiple Myeloma Relapsed Multiple Myeloma |
| Pfizer | INTERVENTIONAL |
| A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants | NCT05963984 | COMPLETED | Metastatic Breast Cancer Locally Advanced Breast Cancer Breast Cancer |
| Carrick Therapeutics Limited | INTERVENTIONAL |
| Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02) | NCT06596694 | RECRUITING | Gastrointestinal Cancer |
| Merck Sharp & Dohme LLC | INTERVENTIONAL |
| Treating Pain in Children With Cancer: Pain Buddy | NCT03384134 | COMPLETED | Cancer |
| University of California, Irvine | INTERVENTIONAL |
| Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma | NCT06876142 | RECRUITING | Multiple Myeloma Relapsed and/or Refractory Multiple Myeloma (RRMM) |
| National Cancer Institute (NCI) | INTERVENTIONAL |
| TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure | NCT03296813 | COMPLETED | Heart Failure |
| Duke University | INTERVENTIONAL |
| Fluid Status of ESRD Patients Undergoing Dialysis | NCT07217470 | RECRUITING | ESRD (End Stage Renal Disease) | N/A | HemoCept Inc. | OBSERVATIONAL |
| A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis | NCT06096779 | RECRUITING | Hepatocellular Carcinoma |
| Genentech, Inc. | INTERVENTIONAL |
| SAGE LEAF 2: An Online Program to Reduce Dementia Caregiver Burden | NCT06708182 | RECRUITING | Caregiving Stress Caregiver Burden |
| Northwestern University | INTERVENTIONAL |
| A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment | NCT07104162 | RECRUITING | Bacterial Infections |
| Qpex Biopharma, Inc. | INTERVENTIONAL |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC | NCT06788990 | RECRUITING | Metastatic Head and Neck Squamous Cell Carcinoma Recurrent Head and Neck Squamous Cell Carcinoma |
| Bicara Therapeutics | INTERVENTIONAL |
| Mitigating the Disinhibiting Effects of Alcohol With Transcranial Magnetic Stimulation | NCT07188376 | NOT_YET_RECRUITING | Alcohol Risk Behaviors |
| Michael J. Wesley, PhD | INTERVENTIONAL |
| Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma | NCT06654050 | NOT_YET_RECRUITING | Mesothelioma Malignant Mesothelioma (MM) Early-stage Mesothelioma Subclinical Mesothelioma |
| National Cancer Institute (NCI) | INTERVENTIONAL |
| A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008) | NCT03976362 | ACTIVE_NOT_RECRUITING | Carcinoma, Squamous Cell, Non-small-cell Lung |
| Merck Sharp & Dohme LLC | INTERVENTIONAL |
| Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease | NCT04795466 | TERMINATED | Mild Cognitive Impairment Alzheimer Disease |
| Novartis Pharmaceuticals | INTERVENTIONAL |
| [Trial of device that is not approved or cleared by the U.S. FDA] | NCT06903351 | WITHHELD | N/A | N/A | [Redacted] | N/A |
Meet Sajad Hussain, your go-to full-stack web development partner.